AFIA AHMED: Open Payments
NPI 1720624141 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $849 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $192 |
| Edwards Lifesciences Corporation | 1 | $178 |
| Lilly USA, LLC | 4 | $155 |
| ABBVIE INC. | 2 | $150 |
| Galderma Laboratories, L.P. | 1 | $106 |
| Novo Nordisk Inc | 3 | $71 |
| QOL Medical, LLC | 2 | $44 |
| Gilead Sciences, Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), VRAYLAR, ZEPBOUND, MOUNJARO, Sucraid, Ozempic, Wegovy, AIRSUPRA.
Industry payments across IL — which companies pay providers there.
